热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Brilliant Violet 605™ anti-mouse/human CD11b
产品名称：
Brilliant Violet 605™ anti-mouse/human CD11b
产品类别：
抗体
产品编号：
101237
产品应用：
101237
[价格]
规格 价格 库存
125µL ￥ 2508 1

产品详情

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605? under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
?L sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the ?g size, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. For flow cytometric staining using the ?l size, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605? excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone M1/70 has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  36. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  2. Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
  3. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  4. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  5. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  6. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  7. Iwahori K, et al. 2019. Sci Rep. 2.205555556. PubMed
  8. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  9. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  10. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  11. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  12. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  13. Rosenheinrich M, et al. 2015. PLoS One. 10: 0136290. PubMed
  14. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  15. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
  16. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  17. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  18. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  19. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  20. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  21. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  22. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  23. Morris MG, et al. 2020. Comp Med. 70:336. PubMed
  24. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  25. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  26. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  27. Bratti M, et al. 2022. Front Immunol. 13:1029759. PubMed
  28. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  29. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  30. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  31. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  32. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  33. Gómez-Díaz C, et al. 2021. iScience. 24:103241. PubMed
  34. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  35. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  36. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  37. Macpherson L, et al. 2020. Nature. 577:266. PubMed
  38. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  39. Christopher S Garris et al. 2018. Immunity. 49(6):1148-1161 . PubMed
  40. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  41. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  42. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  43. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  44. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  45. Niss K, et al. 2020. Cell Reports. 31(11):107763. PubMed
  46. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  47. Iannello A, et al. 2013. J Exp Med. 210:2057. PubMed
  48. Dar HH, et al. 2022. JCI Insight. 7:. PubMed
  49. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  50. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  51. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  52. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  53. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  54. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  55. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  56. McBride KM, et al. 2019. Front Oncol. 9:517. PubMed
  57. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  58. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  59. Campbell C et al. 2018. Immunity. 48(6):1245-1257 . PubMed
  60. Yang C, et al. 2022. Research (Wash D C). 2022:9768687. PubMed
  61. Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed
  62. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  63. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  64. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  65. Sun T, et al. 2017. Mucosal Immunol. 0.954861111. PubMed
  66. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  67. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  68. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  69. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  70. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  71. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  72. Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
  73. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  74. Hamaidi I, et al. 2020. Cell Metabolism. 32(3):420-436.e12. PubMed
  75. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  76. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  77. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  78. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  79. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  80. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  81. Shi H, et al. 2015. Nat Immunol. . PubMed
  82. Macal M et al. 2018. Immunity. 48(4):730-744 . PubMed
  83. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  84. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  85. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  86. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  87. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  88. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  89. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  90. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  91. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  92. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  93. Melhem NJ, et al. 2021. Circulation. 143:566. PubMed
  94. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  95. Crichton M, et al. 2016. Sci Rep. 6:27217. PubMed
  96. Frank AC, et al. 2019. Nat Commun. 10:1135. PubMed
  97. Bommareddy PK, et al. 2019. J Biol Methods. 6:2. PubMed
  98. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  99. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  100. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  101. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  102. White JP et al. 2018. Cell. 175(5):1198-1212 . PubMed
  103. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  104. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  105. Wang T, et al. 2015. Proc Natl Acad Sci U S A. 112:440. PubMed
  106. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  107. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  108. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  109. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  110. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  111. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  112. C Khouili S, et al. 2020. Cell Rep. 33:108468. PubMed
  113. Sparber F et al. 2019. British journal of pharmacology. 176(11):1728-1744 . PubMed
  114. Bretou M, et al. 2017. Sci Immunol. 2:16. PubMed
RRID
AB_11126744 (BioLegend Cat. No. 101237) AB_2565431 (BioLegend Cat. No. 101257)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线